Skip to Main Content
MyYSM
YSM Home

INFORMATION FOR

Rory Shallis, MD

Assistant Professor of Medicine (Hematology)
DownloadHi-Res Photo

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

About

Titles

Assistant Professor of Medicine (Hematology)

Biography

Dr. Shallis received his MD from Rutgers-Robert Wood Johnson Medical School, completed his residency training at Brown University-Rhode Island Hospital and fellowship training at Yale-New Haven Hospital. 

He is focused on the care and research of patients with myeloid malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). He also participated in the K12 Calabresi Immuno-Oncology Training Program and currently participates as an investigator in several clinical trials aimed at improving the outcomes of patients with AML and MDS.

Dr. Shallis also maintains research interest in epidemiological, outcomes and effectiveness research as it pertains to the hematologic malignancies with a goal of identifying barriers to effective care and ultimately strategies to improve the outcomes of patients with these malignant diseases. Dr. Shallis conducts research with the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale University. 

Dr. Shallis has presented his research at multiple regional, national and international meetings and is a member of the National Comprehensive Cancer Network (NCCN) clinical guidelines for MDS and AML panels. He is an author on more than 75 peer-reviewed publications and book chapters, most of which as first author and has served as an ad hoc reviewer for many journals including Leukemia, Haematologica, Blood Advances, Leukemia Research, Leukemia & Lymphoma, Acta Haematologica, Hematology, Therapeutic Advances in Hematology, Expert Review of Hematology, BMC Hematology, eJHaem and Future Oncology among others.

Appointments

Other Departments & Organizations

Education & Training

Fellowship
Yale - New Haven Hospital (2020)
Internship
Brown University - Rhode Island Hospital (2017)
Residency
Brown University - Rhode Island Hospital (2017)
MD
Rutgers University - Robert Wood Johnson Medical School (2014)
BA
Rutgers College, Cell Biology & Neuroscience Psychology (2010)

Research

Overview

Medical Research Interests

Epidemiology; Leukemia; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders

Research at a Glance

Yale Co-Authors

Frequent collaborators of Rory Shallis's published research.

Publications

2024

See All Publications

Clinical Trials

Current Trials

Academic Achievements & Community Involvement

  • activity

    National Comprehensive Cancer Network (NCCN) - Myelodysplastic Syndromes Guideline Panel

    CommitteesMember
  • activity

    Older Adult AML Working Group - National Cancer Institute (NCI) Myeloid Precision Medicine Initiative

    Peer Review Groups and Grant Study SectionsMember
  • activity

    ECOG-ACRIN Leukemia Committee

    CommitteesMember
  • activity

    American Society of Hematology (ASH)

    Professional OrganizationsMember
  • activity

    American Society of Clinical Oncology (ASCO)

    Professional OrganizationsMember
See All Achievements

Clinical Care

Overview

Rory Shallis, MD, received his medical degree from Rutgers-Robert Wood Johnson Medical School, completed his residency training at Brown University-Rhode Island Hospital, and fellowship training at Yale New Haven Hospital.

He is focused on the care and research of patients with myeloid malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). He participated in the K12 Calabresi Immuno-Oncology Training Program and currently participates as an investigator in several clinical trials aimed at improving the outcomes of patients with AML and MDS.

Dr. Shallis also maintains research interest in epidemiological, outcomes, and effectiveness research as it pertains to the hematologic malignancies with a goal of identifying barriers to effective care and ultimately strategies to improve the outcomes of patients with these malignant diseases. Dr. Shallis conducts research with the Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center at Yale University.

Dr. Shallis has presented his research at multiple regional, national, and international meetings and is a member of the National Comprehensive Cancer Network (NCCN) clinical guidelines for MDS and AML panels. He is an author on more than 75 peer-reviewed publications and book chapters, most of which as first author. He has served as an ad hoc reviewer for many journals including Leukemia, Haematologica, Blood Advances, Leukemia Research, Leukemia & Lymphoma, Acta Haematologica, Hematology, Therapeutic Advances in Hematology, Expert Review of Hematology, BMC Hematology, eJHaem, and Future Oncology.

Clinical Specialties

Hematology

Fact Sheets

See All Fact Sheets On Yale Medicine

Board Certifications

  • Hematology (Internal Medicine)

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    2021

  • Internal Medicine

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    2017

Yale Medicine News

See All News On Yale Medicine

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Get In Touch

Contacts

Email
Appointment Number

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    See Patient Care Locations